Terry P Snutch

Title: The Innovations of Terry P. Snutch

Introduction

Terry P. Snutch is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of calcium channel research, particularly in identifying agonists and antagonists of human T-type calcium channels. Her work has implications for understanding various physiological processes and potential therapeutic applications.

Latest Patents

Terry P. Snutch holds a patent for "Methods for identifying agonists and antagonists of human T-type calcium channels." This patent includes sequences and partial sequences for three types of mammalian T-type calcium channel subunits, labeled as the α1, α2, and α3 subunits. Knowledge of these sequences allows for the localization and recovery of the complete sequence from human cells. Furthermore, it enables the development of cell lines that express these novel calcium channels, which can be utilized to identify compounds that act as agonists or antagonists to the calcium channels.

Career Highlights

Throughout her career, Terry has been associated with Neuromed Pharmaceuticals Ltd., where she has focused on advancing research in calcium channels. Her innovative approaches have contributed to the understanding of calcium channel functions and their potential roles in various diseases.

Collaborations

Terry has collaborated with notable professionals in her field, including her coworker David L. Baillie. Their joint efforts have furthered the research and development of calcium channel-related therapies.

Conclusion

Terry P. Snutch's work exemplifies the impact of innovative research in the field of calcium channels. Her contributions continue to pave the way for advancements in medical science and therapeutic development.